Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Jun 20, 2020 | 1 | Complaint (14) |
Apr 14, 2020 | 19 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,673,927 B2; 8,853,156 B2; 9,173,859 B2. (Attachments: # (1) Consent Judgment)(nmf) |
Apr 14, 2020 | 19 | Consent Judgment (4) |
Apr 14, 2020 | 19 | Patent/Trademark Report to Commissioner (1) |
Apr 14, 2020 | 18 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT Signed by Judge Colm F. Connolly on 4/14/2020. (nmf) |
Apr 9, 2020 | 17 | Proposed Consent Judgment (4) Docket Text: PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
Apr 1, 2020 | 16 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME re: Answer Complaint to April 17, 2020 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
Apr 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] STIPULATION TO EXTEND TIME re: Answer Complaint to April 17, 2020 filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Set/Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 4/17/2020; Macleods Pharmaceuticals Ltd. answer due 4/17/2020. Signed by Judge Colm F. Connolly on 4/1/2020. (fms) |
Mar 19, 2020 | N/A | SO ORDERED (0) |
Mar 19, 2020 | 15 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Move, Answer, or Otherwise Respond to Complaint to April 3, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
Mar 6, 2020 | N/A | SO ORDERED (0) |
Mar 6, 2020 | 14 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Move, Answer, or Otherwise Respond to Complaint to March 20, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
Feb 21, 2020 | N/A | SO ORDERED (0) |
Feb 20, 2020 | 13 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to March 6, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
Feb 7, 2020 | N/A | SO ORDERED (0) |
Feb 7, 2020 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME re: Answer to Complaint to February 21, 2020 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
Jan 8, 2020 | N/A | SO ORDERED (0) |
Jan 8, 2020 | 11 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to February 7, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
Dec 26, 2019 | N/A | SO ORDERED (0) |
Dec 23, 2019 | 10 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME re: Answer to Complaint to January 8, 2020 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
Dec 6, 2019 | N/A | SO ORDERED (0) |
Dec 6, 2019 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendants to move, answer, or otherwise respond to the Complaint to December 23, 2019 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
Nov 22, 2019 | N/A | SO ORDERED (0) |
Nov 22, 2019 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME re: Answer Complaint to December 9, 2019 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly) |
Sep 26, 2019 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Macleods Pharma USA, Inc. waiver sent on 9/25/2019, answer due 11/25/2019. (Dellinger, Megan) |
Sep 26, 2019 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Macleods Pharmaceuticals Ltd. waiver sent on 9/25/2019, answer due 11/25/2019. (Dellinger, Megan) |
Sep 25, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Sep 20, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 9/23/2019; Macleods Pharmaceuticals Ltd. on 9/23/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd) |
Sep 20, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (kmd) |
Sep 20, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,673,927 B2; 8,853,156 B2; 9,173,859 B2. (kmd) |
Sep 20, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/8/2019. Date of Expiration of Patent: 5/4/2027, 3/5/2031, 5/4/2027. Thirty Month Stay Deadline: 2/8/2022. (kmd) |
Sep 20, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
Sep 20, 2019 | 1 | Civil Cover Sheet (1) |
Sep 20, 2019 | 1 | Main Document (14) Docket Text: COMPLAINT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2736428.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-3, # (2) Civil Cover Sheet)(kmd) |
Sep 20, 2019 | 1 | Exhibit 1-3 (74) |
Sep 20, 2019 | 1 | Complaint* (1) |